Zobrazeno 1 - 10
of 11
pro vyhledávání: '"van Ipenburg JA"'
Autor:
Privé BM; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Israël B; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Janssen MJR; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., van der Leest MMG; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., de Rooij M; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., van Ipenburg JA; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Jonker M; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Peters SMB; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., de Groot M; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Zámecnik P; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Hoepping A; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Bomers JG; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Gotthardt M; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Sedelaar JPM; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Barentsz JO; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., van Oort IM; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.)., Nagarajah J; From the Department of Medical Imaging and Nuclear Medicine (B.M.P., B.I., M.J.R.J., M.M.G.v.d.L., M.d.R., S.M.B.P., M.d.G., P.Z., J.G.B., M.G., J.O.B., J.N.), Department of Urology (B.I., J.P.M.S., I.M.v.O.), and Department of Radiation Oncology (B.I.), Radboud University Medical Center, Radboud Institute for Health Sciences, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, the Netherlands (B.M.P.); Department of Pathology (J.A.v.I.) and Department of Health Evidence, Biostatistics Section (M.J.), Radboud University Medical Center, Nijmegen, the Netherlands; and Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds, Radeberg, Germany (A.H.).
Publikováno v:
Radiology [Radiology] 2024 May; Vol. 311 (2), pp. e231879.
Autor:
Tolmeijer SH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., van Wilpe S; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Geerlings MJ; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., von Rhein D; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Smilde TJ; Department of Medical Oncology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands., Kloots ISH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Westdorp H; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Coskuntürk M; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, The Netherlands., van Ipenburg JA; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., van der Heijden AG; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Hofste T; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Weiss MM; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Schalken JA; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Ligtenberg MJL; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Mehra N; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Niven.mehra@radboudumc.nl.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Apr; Vol. 7 (2), pp. 282-291. Date of Electronic Publication: 2023 Sep 04.
Autor:
van Ipenburg JA; Department of Pathology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands., van den Bosch QCC; Department of Ophthalmology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Paridaens D; Department of Ophthalmology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Department of Ocular Oncology, The Rotterdam Eye Hospital, Schiedamse Vest 180, 3011 BH Rotterdam, The Netherlands., Dubbink HJ; Department of Pathology, Section Ophthalmic Pathology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Kiliç E; Department of Ophthalmology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Naus N; Department of Ophthalmology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Verdijk RM; Department of Ocular Oncology, The Rotterdam Eye Hospital, Schiedamse Vest 180, 3011 BH Rotterdam, The Netherlands.; Department of Pathology, Section Ophthalmic Pathology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 20; Vol. 24 (16). Date of Electronic Publication: 2023 Aug 20.
Autor:
van Ipenburg JA; Pathology, Erasmus MC, Rotterdam, Netherlands., Naus NC; Ophthalmology, Erasmus MC, Medical Centre, Rotterdam, Netherlands., Dubbink HJ; Erasmus Medical Center, Rotterdam, Zuid-Holland,Netherlands., van Ginderdeuren R; Department of Ophthalmology and Pathology, University Hospital Leuven, Leuven, Belgium., Missotten GS; Ophthalmology, KU Leuven University Hospitals Leuven Gasthuisberg Campus Hospital Pharmacy, Leuven, Flanders, Belgium., Paridaens D; Rotterdam Eye Hospital, Rotterdam, Netherlands., Verdijk RM; Pathology, Erasmus University Medical Center, Rotterdam, Netherlands r.verdijk@erasmusmc.nl/ j.vanipenburg@erasmusmc.nl.
Publikováno v:
The British journal of ophthalmology [Br J Ophthalmol] 2021 Oct; Vol. 105 (10), pp. 1454-1461. Date of Electronic Publication: 2020 Oct 30.
Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis.
Autor:
van Poppelen NM; Department of Ophthalmology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., van Ipenburg JA; Department of Pathology, Section Ophthalmic Pathology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Department of Pathology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands., van den Bosch Q; Department of Pathology, Section Ophthalmic Pathology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Vaarwater J; Department of Ophthalmology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Brands T; Department of Ophthalmology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Eussen B; Department of Ophthalmology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Magielsen F; Department of Clinical Genetics, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Dubbink HJ; Department of Pathology, Section Ophthalmic Pathology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Paridaens D; Department of Ophthalmology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Department of Ocular Oncology, The Rotterdam Eye Hospital, Schiedamse Vest 180, 3011 BH Rotterdam, The Netherlands., Brosens E; Department of Clinical Genetics, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Naus N; Department of Ophthalmology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., de Klein A; Department of Clinical Genetics, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Kiliç E; Department of Ophthalmology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Verdijk RM; Department of Pathology, Section Ophthalmic Pathology, Erasmus MC University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Department of Ocular Oncology, The Rotterdam Eye Hospital, Schiedamse Vest 180, 3011 BH Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 May 28; Vol. 22 (11). Date of Electronic Publication: 2021 May 28.
Autor:
van Ipenburg JA; Section of Ophthalmic Pathology, Department of Pathology, Erasmus MC - University Medical Center, Rotterdam, The Netherlands., Damman J; Section of Ophthalmic Pathology, Department of Pathology, Erasmus MC - University Medical Center, Rotterdam, The Netherlands., Paridaens D; The Rotterdam Eye Hospital, Rotterdam, The Netherlands.; Department of Ophthalmology, Erasmus MC - University Medical Center, Rotterdam, The Netherlands., Verdijk RM; Section of Ophthalmic Pathology, Department of Pathology, Erasmus MC - University Medical Center, Rotterdam, The Netherlands.; The Rotterdam Eye Hospital, Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Ocular oncology and pathology [Ocul Oncol Pathol] 2020 Aug; Vol. 6 (4), pp. 293-296. Date of Electronic Publication: 2020 Jan 28.
Autor:
van Ipenburg JA; Section Ophthalmic Pathology, Department of Pathology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands., Gillis Ing AJM; Department of Pathology, Laboratory for Experimental Patho-Oncology (LEPO), Erasmus MC-University Medical Center, Rotterdam, the Netherlands; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Dorssers LCJ; Department of Pathology, Laboratory for Experimental Patho-Oncology (LEPO), Erasmus MC-University Medical Center, Rotterdam, the Netherlands., van den Bosch QCC; Section Ophthalmic Pathology, Department of Pathology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands., van Ginderdeuren R; Department of Ophthalmology and Pathology, University Hospital Leuven, Leuven, Belgium., Missotten GS; Department of Ophthalmology and Pathology, University Hospital Leuven, Leuven, Belgium., Naus N; Department of Ophthalmology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands., Paridaens D; Department of Ophthalmology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands; The Rotterdam Eye Hospital, Rotterdam, the Netherlands., Looijenga LHJ; Department of Pathology, Laboratory for Experimental Patho-Oncology (LEPO), Erasmus MC-University Medical Center, Rotterdam, the Netherlands; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Verdijk RM; Section Ophthalmic Pathology, Department of Pathology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands; The Rotterdam Eye Hospital, Rotterdam, the Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: r.verdijk@erasmusmc.nl.
Publikováno v:
Ophthalmology [Ophthalmology] 2020 Mar; Vol. 127 (3), pp. 432-434. Date of Electronic Publication: 2019 Oct 12.
Autor:
Coopmans EC; Department of Internal Medicine, Endocrinology Section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands., van Meyel SWF; Department of Internal Medicine, Endocrinology Section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands., Pieterman KJ; Departments of Radiology and Medical Informatics, Biomedical Imaging Group Rotterdam., van Ipenburg JA; Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands., Hofland LJ; Department of Internal Medicine, Endocrinology Section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands., Donga E; Department of Internal Medicine, Endocrinology Section, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands., Daly AF; Department of Endocrinology, University of Liège, Liège, Belgium., Beckers A; Department of Endocrinology, University of Liège, Liège, Belgium., van der Lely AJ; Department of Internal Medicine, Endocrinology Section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands., Neggers SJCMM; Department of Internal Medicine, Endocrinology Section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
European journal of endocrinology [Eur J Endocrinol] 2019 Aug; Vol. 181 (2), pp. K21-K27.
Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions.
Autor:
van Ipenburg JA; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., de Waard NE; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Naus NC; Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands., Jager MJ; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Paridaens D; Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.; The Rotterdam Eye Hospital, Rotterdam, The Netherlands., Verdijk RM; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.; The Rotterdam Eye Hospital, Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2019 Jul 01; Vol. 60 (8), pp. 2950-2957.
Autor:
Ooft ML; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., van Ipenburg JA; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Sanders ME; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Kranendonk M; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Hofland I; Department of Pathology, Core facility Molecular pathology and Biobanking, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands., de Bree R; Department of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Koljenović S; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
Journal of clinical pathology [J Clin Pathol] 2018 Mar; Vol. 71 (3), pp. 267-274. Date of Electronic Publication: 2017 Sep 06.